Advertisement

Payer

Brain cancer drug Gleostine is no longer available for coverage under Medicare Part D after its seller, Miami-based NextSource Biotechnology, removed it from the program, according to The Wall Street Journal.

Point32Health is the name of a new health insurance organization formed by the merger of Tufts Health Plan and Harvard Pilgrim Health Care. 

Advertisement

Civica Rx named the unit that will be tasked with lowering the cost of certain generic medicines, and said one of the nation's largest health insurers — Anthem — will join it.

Advertisement